ORIENT BIO Inc. (002630.KS) KSC

Currency In KRW

AD

Valuation

Market Cap68.54B
Enterprise Value68.54B
P/E Ratio-23.64
PEG Ratio-0.17
Price/Sales Ratio1.64
Price/Book Ratio0.72
Enterprise/Revenue1.46
Enterprise/EBITDA-18.4

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.07
Operating Margin-0.14
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue29.75B
Revenue/Share501.83
Gross Profit0
EBITDA-4.13B
Net Income-2.08B
Diluted EPS-35.14

Balance Sheet

Total Cash33.67B
Total Cash/Share567.88
Total Debt2.13B
Total Debt/Equity0.03
Current Ratio11.45
Book Value Per Share1,142.37

Price History

52-Week Change-48.88
52-Week High1,936
52-Week Low745
Moving Average 50 Days1,008.86
Moving Average 200 Days1,129.31

Statistics

Average Volume495,441
Shares Outstanding59.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:2
Last Split DateJune 09, 2026
AD